Cardiac Involvement of Churg-Strauss Syndrome as a Reversible Cause of Dilated Cardiomyopathy.
- Author:
Hae Chang JEONG
1
;
Kye Hun KIM
;
Jae Yeong CHO
;
Ji Eun SONG
;
Hyun Ju YOON
;
Hyun Ju SEON
;
Youngkeun AHN
;
Myung Ho JEONG
;
Jeong Gwan CHO
;
Jong Chun PARK
Author Information
- Publication Type:Case Report
- Keywords: Churg-Strauss syndrome; Dilated cardiomyopathy; Prognosis
- MeSH: Adult; Brain; Cardiomyopathy, Dilated*; Cerebral Infarction; Churg-Strauss Syndrome*; Cyclophosphamide; Dysarthria; Heart Failure; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Myocarditis; Myocardium; Prognosis; Steroids; Vasculitis
- From:Journal of Cardiovascular Ultrasound 2015;23(1):40-43
- CountryRepublic of Korea
- Language:English
- Abstract: A 31-year-old male who had been treated for Churg-Strauss syndrome (CSS) presented with sudden onset of dysarthria. Brain magnetic resonance imaging (MRI) showed acute multifocal bilateral cerebral infarctions suggesting embolic causes. Cardiac MRI showed dilated cardiomyopathy with severe biventricular dysfunction with intracardiac thrombi, and multiple high signal intensity spots in myocardium of the left ventricle with multifocal delayed enhancement suggesting multifocal myocarditis due to small vessel vasculitis associated with CSS. After anticoagulation therapy, treatments for heart failure, and immunosuppressive therapy including parenteral steroids and cyclophosphamide to control CSS, the symptoms and signs of heart failure and cardiac function of the patient were improved. Considering the pathophysiologic mechanism of cardiac involvement in CSS, immunosuppressive therapy to control the disease activity of CSS should be taken into account, besides usual management for heart failure.
